🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Intermittent Fasting on the Blood Microbiome

RecruitingNAAges 18 Years - 65 YearsAllErasmus Medical Center
NCT06678516 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The investigators previously demonstrated that the gut microbiome can be remodeled by one month of intermittent fasting (OMIF) in healthy volunteers and animal models, with a notable alteration observed in its overall composition which could be linked to improvement in liver function. The blood microbiome, which mirrors the human ecosystem and includes all microbes mainly including bacteria, archaea, and viruses, is a new-identified human microbiome assessment tool that is assumed to be more stable and representative than the gut microbiome, with substantial potential for the diagnosis and prediction of liver cirrhosis and cancer. However, the effect of OMIF, which mimics lifestyle change typically advised in liver disease, on this blood microbiome remains elusive at best. The aim of this study is to explore whether OMIF remodels the composition and function of the blood microbiome in he

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 18-65 years * 18.5 =\< BMI \< 25 kg/m2 * All genders are included. * Have not fasted (go for a day without any food) for any amount of days in the month before the start of the study * Being willing to provide App-derived movement data over the course of the study * Participants are willing to and capable of providing written informed consent. Exclusion Criteria: * Regular use medications such as antibiotics, steroids, beta blockers, and adrenergic-stimulating agents (self-report) * Regular use prebiotic and/or probiotics (self-report) * Intake of antibiotic at least in previous 1 months (self-report) * Daily consumption of \>10 cigarettes, or \>6 cups of coffee (the latter because of the effects on circadian rhythm). (self-report) * Chronic diseases including type 2 diabetes, hypertension, fatty liver disease, cancer, or autoimmune disease (self-report and clinical chemistry) * Internal diseases, including those of the gastrointestinal tract, lung, heart, vasculature, liver, and kidney (self-report and clinical chemistry) * Eating disorder or unconventional eating habits (self-report) * Have a clinically significant abnormality as measured by a blood test * Participation in another study (self-report) * Habit of performing regular fasting (self-report) * Women: pregnancy and breastfeeding (self-report)
💊

What it tests

  • Intermittent fasting
📍

Where

2 sites
Northwest Minzu University
Lanzhou, China
Erasmus Medical Center - Department of Gastroenterology and Hepatology
Rotterdam, Netherlands
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy